Does “99% Purity” Mean the Compound Is Safe for Research Use?

Purity Is One Measurement. It Is Not the Full Picture.

When researchers evaluate a peptide compound, purity percentage is often the first number they look at. It is prominently displayed on product pages, featured in marketing, and cited as the primary quality indicator across the industry. It is also one of the most misunderstood metrics in peptide quality control.

A purity figure tells you something specific and useful. It does not tell you everything. Understanding what it measures, and what it leaves unmeasured, is essential for anyone making procurement decisions based on analytical data.

What Purity Actually Measures

Purity percentage in research peptides is typically determined by HPLC, or high-performance liquid chromatography. This method separates the components of a sample and measures the proportion of the target peptide relative to other peptide-related substances present, including truncated sequences, deletion variants, and synthesis byproducts.

The result is expressed as a percentage. A result of 99% means that 99% of the peptide-related content in the sample corresponds to the intended compound. It is a measurement of peptide composition relative to other peptides.

What Purity Does Not Measure

HPLC purity does not account for non-peptide content in the sample. This includes residual solvents from the synthesis process, water content, counter-ions, and bacterial endotoxins. A compound can return a 99% HPLC purity result and still contain contaminants that fall entirely outside what HPLC is designed to detect.

Endotoxins are a particularly relevant example. These are byproducts of bacterial contamination that can interfere with cell-based assays and in vitro experimental models. They are not captured by standard HPLC analysis. A separate endotoxin test is required to assess their presence. Many suppliers do not perform this test at all.

Residual solvents are another category HPLC does not address. Trifluoroacetic acid, commonly used in peptide purification, remains present in trace amounts in lyophilized compounds unless specifically removed. High TFA content can affect certain in vitro experiments. Standard purity testing does not flag it.

Purity vs. Net Peptide Content

A related distinction that is frequently overlooked is the difference between purity and net peptide content. Purity measures the peptide fraction relative to other peptides. Net peptide content measures the actual peptide mass as a proportion of total sample weight, accounting for water, salts, and counter-ions.

A compound can report 99% purity while containing only 70 to 85% net peptide content by weight. For researchers designing experiments that depend on precise compound concentrations, this distinction has direct implications for how results are interpreted.

What This Means for Research Procurement

A high purity figure from a credible third-party laboratory is a meaningful and necessary quality indicator. It confirms the compound is predominantly the intended peptide and that synthesis byproducts are minimal. That matters.

It does not confirm the compound is free from endotoxins, residual solvents, or other non-peptide contaminants. Researchers working in sensitive assay environments should understand what their supplier tests for and, equally, what they do not.

Asking a supplier directly what their COA covers, and what it does not, is a reasonable and important procurement question. A supplier who can answer it clearly is operating with the transparency that research-grade sourcing requires.

All BioPerform compounds are supplied strictly for research purposes only. Not for human consumption. For use by licensed researchers in controlled laboratory settings.